← All organizations

Cell Genesys

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 1, 2008

Acquired by Genzyme → Sanofi-Aventis on Jan 1, 1999

Timeline

1980s

Jan 1, 1988
Cell Genesys— Founded

1990s

Jan 1, 1999
Genzyme— Acquired By

2010s

Jan 1, 2011
Sanofi-Aventis— Now

Drugs by trial phase (15 distinct, 16 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (10 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT00577356CollaboratorPhase 2Feb 1, 2008
NCT00122005CollaboratorPhase 1/Phase 2Jul 1, 2005
NCT00133224Lead sponsorPhase 3Jul 1, 2005
NCT00116155Lead sponsorPhase 1/Phase 2Jun 27, 2005
NCT00109655Lead sponsorPhase 1Apr 1, 2005
NCT01510288CollaboratorPhase 1Nov 1, 2004
NCT00103428Lead sponsorPhase 1/Phase 2Aug 1, 2004
NCT00089856Lead sponsorPhase 3Jul 1, 2004
NCT00089726Lead sponsorPhase 2Mar 1, 2003
NCT00245362Lead sponsorPhase 2Jun 1, 2002
NCT00140348Lead sponsorPhase 1/Phase 2Dec 1, 2001
NCT00116467Lead sponsorPhase 2Mar 1, 2001
NCT00116441Lead sponsorPhase 1/Phase 2Oct 1, 2000
NCT00140400Lead sponsorPhase 1/Phase 2May 1, 1999
NCT00140387Lead sponsorPhase 1/Phase 2May 1, 1999

Details

Founded: Hayward, CA, US Jan 1, 1988
Last known activity: Feb 1, 2008